ICO KYC Report
Not conducted yet
Ratings
All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
Daniel Lew
CEO at MetaMorph.pro
Rated on Aug 10, 2018
Rated on Aug 10, 2018
5
4
4
11%
Solid team, solid platform and concept, I think the pharmaceutical industry needs a more open source approach not only from clinic to clinic but also to patients aswell. In my opinion clinics should be transparent with patients every step of the way and hope this will bridge the gap.
I like the uniqueness of the platform and using Blockchain to real world use other then just cryptocurrency, this is game-changing.
The whitepaper is very well done. I am impressed with the different versions of whitepapers and level of detail for each.
I also think the scope of 2 years or so as suggested in the roadmap to develop such a platform is bang on.
I think having a live working prototype demo link would be good though during ICO.
Other then that I think it's a great looking business model and wish you all the very best success with the ICO.
+1Agree
+1
Disagree
ReportExperts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.